Holen Sie sich die Stockscreener-App
2.7433
0.18%
-0.0067
Finanzdaten der C 4 Therapeutics Inc-Aktie (CCCC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.91%
11.02
|
11.23 | 6.463 | 7.238 | 15.36 |
Operating Expenses
|
25.15%
34.16
|
45.64 | 34.96 | 36.40 | 43.61 |
| Benefits Costs and Expenses |
27.69%
31.38
|
43.40 | 32.48 | 33.56 | 40.03 |
| Costs And Expenses |
27.69%
31.38
|
43.40 | 32.48 | 33.56 | 40.03 |
| Operating Income/Loss |
32.74%
-23.14
|
-34.41 | -28.50 | -29.16 | -28.24 |
| Nonoperating Income/Loss |
23.78%
2.78
|
2.246 | 2.481 | 2.842 | 3.578 |
| Income/Loss From Continuing Operations Before Tax |
36.69%
-20.36
|
-32.17 | -26.02 | -26.32 | -24.67 |
| Income Tax Expense/Benefit |
0.121
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
36.31%
-20.49
|
-32.17 | -26.02 | -26.32 | -24.67 |
|
Net Income/Loss
|
36.31%
-20.49
|
-32.17 | -26.02 | -26.32 | -24.67 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
84.26%
11.42
|
72.56 | 71.01 | 70.83 | 69.63 |
| Diluted Average Shares |
84.26%
11.42
|
72.56 | 71.01 | 70.83 | 69.63 |
| Basic Earnings Per Share |
79.55%
-0.09
|
-0.44 | -0.37 | -0.37 | -0.35 |
| Diluted Earnings Per Share |
79.55%
-0.09
|
-0.44 | -0.37 | -0.37 | -0.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):